Showing 1,021 - 1,040 results of 3,189 for search '"vaccination"', query time: 0.10s Refine Results
  1. 1021

    Confidence in the efficacy of routine vaccines after the COVID-19 pandemic: a cross-sectional web-based study by Areej M. Zubaid, Maha T. Alhamdi, Noor I. Al-Harthi, Khulood M. Al-Harthi, Razan A. AlQarni, Yassmin M. Shebany, Ahmed Ibrahim Fathelrahman, Sayed F. Abdelwahab

    Published 2024-12-01
    “…Abstract Background There is limited data that assessed the changes in public confidence in routine childhood and adult vaccines after Corona Virus Disease-2019 (COVID-19) pandemic. …”
    Get full text
    Article
  2. 1022

    Comprehensive Analysis of the Immune Response to SARS-CoV-2 Epitopes: Unveiling Potential Targets for Vaccine Development by Huixiong Deng, Yanlei Li, Gefei Wang, Rui Li

    Published 2025-01-01
    “…Our analysis uncovered key immune responses linked to preventing viral infection and viral clearance, emphasized areas of interest for broad-spectrum SARS-CoV-2 vaccine development, and offered insights for future research and clinical applications.…”
    Get full text
    Article
  3. 1023
  4. 1024

    Three Types of Broadly Reacting Antibodies against Influenza B Viruses Induced by Vaccination with Seasonal Influenza Viruses by Daisuke Hirano, Nobuko Ohshima, Ritsuko Kubota-Koketsu, Ayami Yamasaki, Gene Kurosawa, Yoshinobu Okuno, Shunji Yoshida, Yoshikazu Kurosawa

    Published 2018-01-01
    “…We analyzed the antibody (Ab) repertoire against influenza B viruses induced by vaccination with seasonal influenza viruses in one individual who had never been vaccinated until 2009. …”
    Get full text
    Article
  5. 1025
  6. 1026
  7. 1027

    Malaria: Factors affecting disease severity, immune evasion mechanisms, and reversal of immune inhibition to enhance vaccine efficacy. by Xin-Zhuan Su, Fangzheng Xu, Rachel V Stadler, Awet Alem Teklemichael, Jian Wu

    Published 2025-01-01
    “…There have been some successes in developing vaccines against the disease recently, but the vaccine efficacies require improvement. …”
    Get full text
    Article
  8. 1028
  9. 1029
  10. 1030
  11. 1031

    Neonatal BCG vaccination and child survival in TB-exposed and TB-unexposed children: a prospective cohort study by Peter Aaby, Per Kallestrup, Christine Stabell Benn, Sanne M Thysen, Ane Fisker, Victor Francisco Gomes, Frauke Rudolf, Christian Wejse, Adam Roth

    Published 2020-02-01
    “…Objectives To assess the association between neonatal BCG vaccination and mortality between 28 days and 3 years of age among tuberculosis (TB)-exposed and TB-unexposed children.Design Prospective cohort study.Setting Bandim Health Project runs an urban Health and Demographic Surveillance site in Guinea-Bissau with registration of mortality, vaccination status and TB cases.Participants Children entered the analysis when their vaccination card was inspected after 28 days of age and remained under surveillance to 3 years of age. …”
    Get full text
    Article
  12. 1032
  13. 1033

    Prophylactic mRNA Vaccination against Allergy Confers Long-Term Memory Responses and Persistent Protection in Mice by E. Hattinger, S. Scheiblhofer, E. Roesler, T. Thalhamer, J. Thalhamer, R. Weiss

    Published 2015-01-01
    “…Recently, mRNA vaccines have been introduced as a safety-optimized alternative to plasmid DNA-based vaccines for protection against allergy. …”
    Get full text
    Article
  14. 1034
  15. 1035
  16. 1036
  17. 1037
  18. 1038
  19. 1039
  20. 1040